6e6d9be8519d8e2e33709397c445b177 *DESCRIPTION
6b6274e6065eb5762ca6ebccf7258a78 *INDEX
122477424e4d053d880a5529d1a26d50 *Meta/Rd.rds
df6cc038517949d2458c915e8c2717d7 *Meta/data.rds
9f7a4637f056aa0787fb29bc9c21a1ff *Meta/features.rds
97fd934032df4ac456702c9c136a3ba6 *Meta/hsearch.rds
de18284e401cb2cd884b3e838529b597 *Meta/links.rds
4d270983391b58c67a677b48d4f88805 *Meta/nsInfo.rds
ee12244dc9004becda920a1b74d6eb69 *Meta/package.rds
58f6e0b05164e17c09590643e0565b98 *Meta/vignette.rds
1402411f0afafec39a66d6c5749f0b12 *NAMESPACE
1b5cdb5c1dc5f9d60f07d81ca0b2c70e *NEWS.md
d6c68f1fe41ced6e98a766a3757313da *R/nlmixr2lib
5aa13ef51c1590b6954cda40293d27df *R/nlmixr2lib.rdb
1e714fa0d0be0a23855596acec403d53 *R/nlmixr2lib.rdx
195be3d2245f50002da09db78cd2c662 *WORDLIST
60f0c176e273e095d57aa370a78e7b95 *data/Rdata.rdb
63c6f83aa53138695594e0c4117e1ec0 *data/Rdata.rds
a181d6e3aa5cdead061bf32b0c75ea23 *data/Rdata.rdx
43f6f19aba9e9c0d70d5012c95a6aa49 *doc/create-model-library.R
f61274d5953bdddf85dd1be0b8c8b38a *doc/create-model-library.Rmd
44cf17b4d0070d97a1afad000177ec2a *doc/create-model-library.html
502a917c305d2c421558cd3ac3c84598 *doc/index.html
13f214d0327371b6efcc1a93829a7cbf *help/AnIndex
36d4794c0bead9d02da466382033f1ce *help/aliases.rds
3e16d16cc8f8b43e1b5d30bc3ea25b2c *help/nlmixr2lib.rdb
378f7219e548400d6ad5db47f2572434 *help/nlmixr2lib.rdx
e7ceb73c697e3052a988d1d1756a2176 *help/paths.rds
eb77a7ea08800c8d7f2a41edb43d6f32 *html/00Index.html
3845aef6126cf18c45937f292f23508c *html/R.css
e305a02483fd7ad395074558033b0c42 *modeldb/PK_1cmt.R
2c7143e9a8826ba9a723b55ed548ebb7 *modeldb/PK_1cmt_des.R
e9c87fecf5962821f9d2d3167f3c1ea7 *modeldb/PK_2cmt.R
1eb68026965927d01e46915fe5062e5d *modeldb/PK_2cmt_des.R
95e64cede819fab3c6bc58e508e475fc *modeldb/PK_2cmt_tdcl_des.R
a54c7e1884d95b11a8d83a880cd408e4 *modeldb/PK_3cmt.R
2cdfb7c25828968e1aa7f331baa0cd93 *modeldb/PK_3cmt_des.R
c2f719b77fee413b6b7fd637b417baf7 *modeldb/pharmacokinetics/PK_2cmt_mAb_Davda_2014.R
ba852c5df5365decbd81d0ef9cb2e88e *modeldb/specificDrugs/Kovalenko_2020_dupilumab.R
23091e6212764636d6d0da5e8c0b3414 *modeldb/specificDrugs/Soehoel_2022_tralokinumab.R
4014f3b1b9b9a8b2c234c8a371904803 *modeldb/specificDrugs/Zhu_2017_lebrikizumab.R
8b09b44e16dcd985bd4513ac662083f6 *modeldb/therapeuticArea/oncology_sdm_lobo_2002.R
fd394f1e21626e3c8a5fe31f0117ae8e *modeldb/therapeuticArea/oncology_xenograft_simeoni_2004.R
